National Costs and Resource Requirements of External Beam Radiotherapy: A Time-driven Activity-based Costing Model from the ESTRO-HERO Project
Overview
Authors
Affiliations
Background: The Health Economics in Radiation Oncology (ESTRO-HERO) project aims to provide a knowledge base for health economics in European radiotherapy. A cost-accounting model, providing data on national resource requirements and costs of external beam radiotherapy (EBRT), was developed.
Materials And Methods: Time-driven activity-based costing (TD-ABC) was applied from the healthcare provider perspective at national level. TD-ABC allocates resource costs to treatment courses through the activities performed, based on time estimates.
Results: The model is structured in three layers. The central layer, EBRT-Core, accounts for EBRT care-pathway activities and follows TD-ABC allocation principles. Activities supporting radiation oncology (RO) (RO-Support) and multidisciplinary oncology (Beyond-EBRT) follow standard allocation principles. To demonstrate the model's capabilities, a dataset was constructed for the hypothetical country Europalia, based on published evidence on resources and treatments, whereas time estimates were expert opinions. Applying the TD-ABC model to this example, treatment delivery activities represent 68.4% of the costs; treatment preparation 31.6%. The cost per course shows large variation for different indications, techniques, and fractionation schedules, ranging between €838 and €7193. Resource utilization was estimated to be within the available capacity. Scenario analyses on changes in fractionation and treatment complexity are presented. The ESTRO-HERO TD-ABC tool can model EBRT costs and resource requirements. While the Europalia example illustrates its potential, the results cannot be generalized nor used as a proxy for national evidence. Only real-world data, tailored to the specificities of individual countries, will support National Radiation Oncology Societies with investment planning and access to innovative radiotherapy.
Challenges in assessing national radiotherapy costs: application of the ESTRO-HERO model in Spain.
Corral J, Algara M, Munoz-Montplet C, Eraso A, Giralt J, Defourny N Front Public Health. 2025; 12:1474376.
PMID: 39749236 PMC: 11694224. DOI: 10.3389/fpubh.2024.1474376.
Maia F, da Conceicao Vasconcelos K, Carvalho H, de Soarez P BMC Health Serv Res. 2024; 24(1):1466.
PMID: 39587569 PMC: 11590574. DOI: 10.1186/s12913-024-11969-y.
Lu Q, Wu Y, Mao X, Wan H, Shao J, Yu Q Heliyon. 2024; 10(9):e30668.
PMID: 38774097 PMC: 11107096. DOI: 10.1016/j.heliyon.2024.e30668.
Aggarwal A, Court L, Hoskin P, Jacques I, Kroiss M, Laskar S BMJ Open. 2023; 13(12):e077253.
PMID: 38149419 PMC: 10711912. DOI: 10.1136/bmjopen-2023-077253.
Iachecen F, Dallagassa M, Portela Santos E, Carvalho D, Ioshii S BMC Health Serv Res. 2023; 23(1):1408.
PMID: 38093275 PMC: 10720189. DOI: 10.1186/s12913-023-10411-z.